Library

Gender differences in clinical registration trials: is there a real problem?

2 January 2018. doid: 10.1111/bcp.13497

Labots G, Jones A, de Visser SJ, Rissmann R, Burggraaf J

View publication

Several studies have reported the under-representation of women in clinical trials, thereby challenging the external validity of the benefit/risk assessments of launched drugs. Our aim was to determine the extent to which women have been included in clinical trials used for drug registration and to analyse the fraction of women participating in phases I, II and III.

Advancing the boundaries of clinical drug development

Wondering how we can help you? Reach out to us.

Get in contact
contact